MeFAMP PET scan to image brain tumors and spread
Part of Cancer clinical trials.
This early study tests whether a special PET scan drug (MeFAMP) can help doctors see primary and spreading brain tumors. It may help identify tumor areas more clearly, which could guide treatment planning.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must be expected to live more than 12 weeks.
- If you can get pregnant: you need a negative urine pregnancy test on procedure day or a blood pregnancy test within 48 hours before the dose.
- You must not be pregnant or breastfeeding.
- You must be able to finish the PET scan tests the study requires.
- Your kidneys and liver should work well enough (kidney filtration rate must be at least 60).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses special scans (PET and MRI) to look at brain tumors in more detail. It aims to understand tumor metabolism and oxygen levels, which may help guide treatment.
This early-phase study uses special PET/MRI scans to look at how a newly diagnosed high-grade glioma is changing under standard treatment. The goal is to see whether these scans can better assess the disease, which may help guide future care.
This trial tests whether a special PET scan can tell the difference between actual tumor growth and treatment-related changes in people with aggressive brain cancer (high-grade glioma). If you have had radiation and an MRI shows a growing lesion, this study may help clarify the cause.
This trial studies a special PET scan called 18F-DOPA PET/CT to see if it can help doctors better manage brain tumors. It may be used before surgery, for radiation planning, or when MRI results are unclear.
This study uses a special PET/MR scan to look at certain cells called cancer-associated fibroblasts in glioblastoma brain tumors. It aims to see if this imaging approach can better detect tumors or their recurrence, helping guide treatment decisions.
This trial tests how well a special PET/MRI scan can help doctors evaluate gliomas and brain metastases. It may help improve diagnosis and treatment planning by comparing scan results with tissue samples or surgery findings.
Hear when a new Recurrent Glioma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.